Creoptix raises CHF8m Series C financing round
Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, has raised CHF8 million in the first closing of a Series C financing round. The round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation (NYSE: WAT) as well as existing private investors. Robert Schier of

